| Total patients (n = 572) | (%) | TBB patients (n = 236) | (%) | Re-biopsy in TBB patients (n = 24) | (%) | |
---|---|---|---|---|---|---|---|
Age-median, [range] | Median | 68 [25–93] |  | 68 [25–93] |  | 67 [25–79] |  |
Sex-no. (%) | Male | 365 | (63.8) | 143 | (60.6) | 10 | (41.6) |
Female | 207 | (36.2) | 93 | (39.4) | 14 | (58.4) | |
Histology-no. (%) | Ad including | 396 | (69.2) | 160 | (67.8) | 14 | (58.4) |
 Ad + SCLC | 2 |  | 0 |  | 0 |  | |
 Ad + Sq | 2 |  | 0 |  | 0 |  | |
Sq | 99 | (17.3) | 50 | (21.2) | 5 | (20.8) | |
NSCLC | 77 | (13.5) | 26 | (11.0) | 5 | (20.8) | |
Stage-n. (%) | IVA, B | 416 | (72.7) | 171 | (72.5) | 21 | (87.5) |
IIIA,B,C | 140 | (24.5) | 55 | (23.3) | 3 | (12.5) | |
IIA, B | 16 | (2.8) | 10 | (4.2) | 0 | Â | |
Tumor location.1 | Central | Â | Â | 69 | (29.2) | 14 | (58.4) |
Peripheral | Â | Â | 167 | (70.8) | 10 | (41.6) | |
Tumor location.2 | Right | Â | Â | Â | Â | Â | Â |
 Upper and Middle |  |  | 82 | (34.7) | 10 | (41.6) | |
 Lower |  |  | 42 | (17.8) | 6 | (25.0) | |
Left | Â | Â | Â | Â | Â | Â | |
 Upper |  |  | 67 | (28.4) | 4 | (16.7) | |
 Lower |  |  | 45 | (19.1) | 4 | (16.7) | |
Maximum diameter of tumor.(mm) | Median [range] |  |  | 39.3 [14.7–102.3] |  | 49.5 [15.6–82.0] |  |
ROSE | Positive | Â | Â | Â | Â | 21 | (87.5) |